FIELD: medicine.
SUBSTANCE: group of inventions refers to using the inhibitor of chloride ion transport to neurons which represents bumetanide, a Na-K-Cl co-transporter inhibitor, or bumetanide aldehyde, bumetanide dibenzylamide, bumetanide diethylamide, bumetanide morpholinoethyl ester, bumetanide 3-dimethylaminopropyl ester, bumetanide N,N-diethylglycolamide ester, bumetanide dimethylglycolamide ester, bumetanide pivaxetil ester, bumetanide methoxy-(polyethylenoxy)n-i-ethyl ester, bumetanide benzyltrimethyl ammonium salt and bumetanide cetyltrimethyl ammonium salt for treating autism, and to using the based pharmaceutical composition.
EFFECT: efficacy in accordance with the claimed application with no adverse side effects.
3 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF | 2013 |
|
RU2704228C2 |
| METHODS FOR INDUCING AND PROLONGING SATURATION, REDUCING VOLUME AND ABSORPTION OF FOOD, CONTROLLING WEIGHT AND STIMULATING WEIGHT LOSS | 2017 |
|
RU2766585C2 |
| VECTOR, METHOD FOR TREATING CHOROIDITIS, METHOD FOR SELECTIVE EXPRESSION OF POLYNUCLEOTIDE | 2014 |
|
RU2723101C2 |
| USE OF A COMPOSITION CONSISTING OF THE AMINO ACIDS GLYCINE, ARGININE, CYSTEINE AND RESVERATROL TO REDUCE THE SEVERITY OF DIABETES AND HIGH CONTENT OF FAT, CHOLESTEROL, URIC ACID, BLOOD GLUCOSE AND ACCELERATED AGING IN ANIMALS AND HUMANS | 2017 |
|
RU2749950C2 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2797200C1 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2812207C2 |
| MONOCLONAL ANTIBODIES AGAINST CLAUDIN 1 FOR PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA | 2016 |
|
RU2770021C2 |
| AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF CHILDHOOD AUTISM OF MILD SEVERITY, ATYPICAL AUTISM AND SCHIZOPHRENIA IN CHILDREN | 2022 |
|
RU2808675C1 |
| VACCINE AGAINST INTERMEDIATE WITH AMYLOID COAGULATION | 2009 |
|
RU2546234C2 |
